Thus, our study has revealed a novel mechanism behind HCC migration and metastasis through the MTBP-IPO7-Erk1/2-Elk-1 axis and suggests that reduced MTBP could serve as a novel biomarker of HCC metastasis. Here, IPO7 is linked to hepatocellular carcinoma.